*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Srishti Bhutani
PhD Defense Presentation
Day: Monday, Jan 9th, 2017
Time: 10:00 AM
Location: HSRB E-360 (Emory University)
Committee members:
Michael E. Davis, PhD (Advisor)
Andres J. Garcia, PhD
W. Robert Taylor, MD, PhD
Younan Xia, PhD
Chunhui Xu, PhD
Title: Investigating scaffold designs to enhance progenitor cell-based cell therapy for myocardial repair
Abstract:
Cell therapy for congestive heart failure has shown promising results in preclinical studies but results of clinical trials suggest the need for this modality to be optimized. C-kit+ cardiac progenitor cells (CPCs) are adult stem cells that have been shown to differentiate toward lineages of the heart and exert beneficial paracrine effects. Their injection in humans resulted in moderate but insufficient improvements in cardiac function after myocardial infarction. In this project, we studied two strategies for enhancing CPC based-cell therapy using tunable maleimide-crosslinked poly(ethylene glycol) (PEG-MAL) hydrogels. In the first strategy, CPCs were encapsulated in PEG-MAL hydrogels presenting vascular endothelial growth factor (VEGF). Although activation of ERK signaling was observed in CPCs encapsulated in VEGF presenting PEG gels, this strategy failed to induce endothelial differentiation or modulate paracrine effects of CPCs in vitro. Different growth factor doses, cell populations and biomaterial density and degradation rates were tested. In the second strategy, CPCs were encapsulated in integrin-specific hydrogels. α2β1-specific hydrogels induced cardiomyocyte differentiation of CPCs accompanied by a reduction in expression of secreted factors in vitro. Interestingly, following injection in rats undergoing ischemia-reperfusion, treatment with CPCs encapsulated in non-adhesive hydrogels resulted in the greatest preservation of cardiac contractility and attenuation of post-infarct remodeling. Overall, this work adds to our knowledge of CPC behavior in presence of stimuli relevant to pragmatic design of regenerative therapies, as well as broadens our understanding of design principles that may be used to augment effects of cell therapy for myocardial repair.
